Kalaris Therapeutics, Inc. ($KLRS)
Filing Information
| Accession Number | 0001193125-26-257471 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 4, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
9,000
Total Value
$0.00
P&L
+inf% (+$36,450.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Stock Option (Right to Buy) | Derivative | Jun 3, 2026 | Grant/Award | 9,000 | $0.00 | $0.00 | 9,000 | Direct | โ | View Details |